Tom20 (D8T4N) Rabbit Monoclonal Antibody… and 4 more items

The University of Nebraska Medical Center, a state institution in Nebraska, awarded a purchase order to Cell Signaling Technology Inc., a vendor based in Boston, Massachusetts, for the procurement of five rabbit monoclonal antibodies designated for research purposes. The contract, issued February 12, 2026, with purchase order number 4800179060, encompasses the following line items: Tom20 (D8T4N) at $154.00, OPA1 (D6U6N) at $173.00, PSD95 (D74D3) at $159.00, Synaptophysin (D8F6H) at $188.00, and COX IV (3E11) at $152.00. The total contract value is $826.00 for one unit of each antibody.

Performance of this purchase order commenced on the award date of February 12, 2026, with completion scheduled for March 2, 2026. Delivery is designated F.O.B. destination with freight prepaid to the University of Nebraska Medical Center's Shipping and Receiving department located at 601 South Saddle Creek Road, Omaha, Nebraska. The transaction is governed by the Standard Terms of Purchase established by the University of Nebraska Board of Regents, with payment terms of Net 30, and the vendor is required to acknowledge acceptance within ten days of the order date.